Brevan Howard Capital Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
28,170
+2,865
+11% +$9.73K ﹤0.01% 1950
2026
Q1
$44.5K Sell
25,305
-124,203
-83% -$269K ﹤0.01% 2094
2025
Q4
$351K Buy
+149,508
New +$409K ﹤0.01% 1289
2025
Q2
Sell
-245,575
Closed -$882K 1860
2025
Q1
$882K Buy
+245,575
New +$986K 0.01% 547
2023
Q4
Sell
-28,693
Closed -$31K 1024
2023
Q3
$31K Buy
+28,693
New +$34.1K ﹤0.01% 374

Other funds holding CLOV

Brevan Howard Capital Management's CLOV Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Clover Health Investments (CLOV) stake by 11% in Q2 2026, buying an estimated $9.73K and bringing the position to 28,170 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Brevan Howard Capital Management first reported a position in CLOV in Q3 2023 and has held it in 5 quarters since. The position peaked at $882K in Q1 2025. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Brevan Howard Capital Management held 28,170 shares of Clover Health Investments worth $148K as of Q2 2026.
  • Brevan Howard Capital Management bought 2,865 Clover Health Investments shares in Q2 2026, an estimated $9.73K.
  • Clover Health Investments made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1950 holding.
  • Brevan Howard Capital Management first reported a position in Clover Health Investments in Q3 2023 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Clover Health Investments position peaked at $882K in Q1 2025.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.